To commemorate Mahatma Gandhi’s anniversary and his vision for a Leprosy-Free India, Rotary International District 3011 together with Delhi Fellowship for Cycling to Serve and Delhi Public School conducted a mega cycle rally to raise awareness about Leprosy and Polio in the august presence of Vice Chairman and Director of Education, NDMC. It’s been over […]
Indus Health Plus, a pioneer in the preventive healthcare sector, launched COVIDNAwise, a revolutionary genomics test to know the predisposition of COVID-19. The test will inform genetic risks about 18 parameters under three categories – Susceptibility and Severity of COVID-19, Nutrition & COVID-19, and Co-morbidities of COVID-19. Since the breakout of this pandemic, various research […]
A frontrunner in delivering a healthy and sustainable living, Livpure has rolled yet another futuristic range that is a big breakthrough in RO (Reverse Osmosis) based water purifiers. According to Asian Development Bank’s forecast, by 2030, India will have a water deficit of 50 percent. Livpure has launched various campaigns in the past like #CuttingPaani […]
FICCI recently announced its annual healthcare conference – FICCI HEAL 2020 from 29th September 2020 to 1st October 2020. The 14th edition of FICCI HEAL on the theme, “Post-COVID Healthcare World – The New Beginning” is scheduled on a virtual platform and will include Keynote Addresses, Panel Discussions as well as Plenary Sessions covering the entire spectrum […]
Roche Products (India) Pvt. Ltd. (Roche Pharma) and Entero Healthcare Solutions Pvt. Ltd. (Entero) today announced that the two companies have entered into an agreement to provide better access to innovative medicines for patients in India. Under this agreement, Entero will be responsible for promotion, marketing and distribution of Roche Pharma’s key nephrology drugs viz., […]
Cipla Limited (BSE: 500087) (NSE: CIPLA EQ), hereinafter referred to as “Cipla”), today announced the launch of remdesivir under its brand name CIPREMI. The U.S. FDA issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc. for emergency use of remdesivir for the treatment of hospitalized 2019 coronavirus disease (COVID-19) patients. It is the only […]
